First-in-man study · phase of a clinical trial studying safety and dosage · YYNN

First-in-man study

? TBD

phase of a clinical trial studying safety and dosage

Ratings
0

Nobody has rated this yet. Be the first!

Subject of
3

In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials

scientific article published on November 2006

Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054

scientific article published on 17 June 2019

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

scientific article

Lists
0

Subclass of

Followed by

phase II clinical trial

Wikidata